Originally published byThe Hill
The Food and Drug Administration (FDA) is moving ahead with a safety review of the abortion pill mifepristone, according to an administration official. The move marks a victory for anti-abortion groups that could pave the way for the Trump administration to restrict its use and how it can be distributed. The retrospective analysis of data…
🇺🇸
More news from United StatesUnited States
NORTH AMERICA
Related News
Trump’s Lebanon crisis: Why paper ceasefires fail
6h ago
How DDHQ projected Raman over Pratt in Los Angeles mayoral race
1d ago
New York City tightens security ahead of Trump appearance at NBA Finals
1d ago
What is Freedom 250 and why are musical artists distancing themselves from its concerts?
1d ago
Morning Update: Ottawa to roll back new CRTC contribution requirements
1d ago